The Scale of Africa’s Biosafety Double-Standard
This is a guest post from the BiotechBlog Intern, Fintan Burke. Fintan is a student at the School of Biotechnology […]
General Biotechnology
General Biotechnology
Drug Patent Expirations for Apr 22 2012
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
 <!–/td> |
This
newsletter is a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Simple flat-rate | ||||||||||||||||||||
| Ultimate Plan | Premium Plan | Basic Plan | |
| One year | $1,995  | $1,795  | $1,095 |
| One month | $525 | $425 | $325 |
| 48 hours | $95 | $75 | |
| Plan comparison Site tour Contact | |||
Drug Patent Expirations for Apr 22 2012
DrugPatentWatch Fills Your Competitive Intelligence | ||||||||||||||||||||||||||||||
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details
DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
General Biotechnology
Drug Patent Expirations for Apr 25 2012
If your reader cannot render the information below, go to
http://www.DrugPatentWatch.com/innovation to see the latest expirations
 |
| ADVERTISE HERE |
This
newsletter is a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs,
developers, and their patents
Simple flat-rate | ||||||||||||||||||||
| Ultimate Plan | Premium Plan | Basic Plan | |
| One year | $1,995 | $1,795 | $1,095 |
| One month | $525 | $425 | $325 |
| 48 hours | $95 | $75 | |
| Plan comparison Site tour Contact | |||
Drug Patent Expirations for Apr 25 2012
DrugPatentWatch Fills Your Competitive Intelligence | ||||||||||||||||||||||||||||||
The above list
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details
does not discriminate between dominant and non-dominant patents. Drugs
listed above may be protected by additional patents and other regulatory
protections. See the DrugPatentWatch
database for complete details
DISCLAIMER:
Although great care is taken in the proper and correct provision of this
service, thinkBiotech LLC does not accept any responsibility for possible
consequences of errors or omissions in the provided information. There is
no warranty that the information contained herein is error free. Users of
this service are advised to seek professional advice and independent
confirmation before acting on any of the provided information. thinkBiotech
LLC reserves the right to amend, extend or withdraw any part or all of the
offered service without notice.
All trademarks and applicant names
are the property of their respective owners or
licensors.
